40
Participants
Start Date
June 15, 2021
Primary Completion Date
October 30, 2023
Study Completion Date
December 30, 2024
NASOX
Oxalipatin 60 mg/m2 IV (2 h infusion) on Day 1, every 2 weeks Nal-IRI 50-60 mg/m2 IV (FBE, 90 min infusion) on Day 1, every 2 weeks S-1 40mg/m2 oral twice daily on Day 1-7, every 2 weeks
Hallym University Medical Center, Anyang-si
Asan Medical Center, Seoul
Lead Sponsor
Hallym University Medical Center
OTHER
Asan Medical Center
OTHER